bpc-157 human clinical trial safety adverse events and the Difference Between an Evidence Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — WellFounded Peptides and BPC-157 for Pain:

Plenty of useful drugs do their job while the textbook explanation stays fuzzy

[1] The prevalence of clinically diagnosed BPH peaks at 24% in men aged 7579 years

Biotin may interact with: Certain laboratory assays , potentially causing inaccurate thyroid or hormone test results High-dose biotin supplementation may interfere with specific lab diagnostics Clinical judgment should guide concurrent therapy and laboratory monitoring

When They Should Not Be First-Line Therapy Despite their efficacy, novel weight loss peptides should generally not replace GLP-1 or GIP receptor agonists as initial therapy for uncomplicated obesity

A single unusual case report did describe a life-threatening eosinophilic pneumopericardium effusion (a type of fluid accumulation around the lungs and heart with high eosinophil counts) in an elderly woman who had been concurrently taking high-dose pantothenic acid (vitamin B5 at 300 mg/day) and biotin (10 mg/day) for two months